A Case of Polymyxin b-Immobilized Fiber Column Treatment for Rapidly Progressive Interstitial Pneumonia Associated with Clinically Amyopathic Dermatomyositis

<table>Chest X-rays and computed tomography (CT) scans of the patient with clinically amyopathic dermatomyositis (C-ADM) before and after polymyxin b-immobilized fiber column hemoperfusion (PMX) treatment. Day 0, on admission. Day 7, improvement after initial treatment. Day 15, before relapse. Day 29, on relapse and before PMX treatment. Day 33, improvement after PMX treatment (on days 30 and 31). Day 50, twenty days after PMX treatment.</table>

Case Reports in Medicine

fig2

Figure 2

Figure 2: A Case of Polymyxin b-Immobilized Fiber Column Treatment for Rapidly Progressive Interstitial Pneumonia Associated with Clinically Amyopathic Dermatomyositis 

Figure 2 | A Case of Polymyxin b-Immobilized Fiber Column Treatment for Rapidly Progressive Interstitial Pneumonia Associated with Clinically Amyopathic Dermatomyositis 